MOONLAKE IMMUNOTHERAPEUTICS's ticker is and the CUSIP is 61559X104. A total of 122 filers reported holding MOONLAKE IMMUNOTHERAPEUTICS in Q3 2023. The put-call ratio across all filers is 13.14 and the average weighting 1.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 21,751,284 | $1,239,823,188 | 33.43% |
| Cormorant Asset Management, LP | 8,142,100 | $464,099,700 | 27.07% |
| Ally Bridge Group (NY) LLC | 183,105 | $10,436,985 | 12.25% |
| Finepoint Capital LP | 331,416 | $18,890,712 | 9.41% |
| Ghost Tree Capital, LLC | 330,000 | $18,810,000 | 6.19% |
| 5AM Venture Management, LLC | 313,210 | $17,852,970 | 5.14% |
| Ghost Tree Capital, LLC | 250,000 | $14,250,000 | 4.69% |
| MPM BioImpact LLC | 294,190 | $16,768,830 | 4.48% |
| Integral Health Asset Management, LLC | 500,000 | $28,500,000 | 3.95% |
| Altium Capital Management LP | 88,000 | $5,016,000 | 2.62% |
| Velan Capital Investment Management LP | 55,300 | $3,152,100 | 2.54% |
| Avidity Partners Management LP | 777,172 | $44,298,804 | 1.78% |
| Avoro Capital Advisors LLC | 1,999,999 | $113,999,943 | 1.78% |
| SVB FINANCIAL GROUP | 16,173 | $921,861 | 1.73% |
| HighVista Strategies LLC | 59,769 | $3,406,833 | 1.58% |
| CHI Advisors LLC | 60,000 | $3,420,000 | 1.36% |
| Monashee Investment Management LLC | 50,000 | $2,850,000 | 1.19% |
| SECTORAL ASSET MANAGEMENT INC | 97,965 | $5,584,005 | 1.09% |
| Sofinnova Investments, Inc. | 292,805 | $16,689,885 | 1.05% |
| Tri Locum Partners LP | 53,300 | $3,038,100 | 0.97% |
This page lists MOONLAKE IMMUNOTHERAPEUTICS's shareholders in Q3 2023. To view MOONLAKE IMMUNOTHERAPEUTICS's shareholder history, click here.